Karlsruhe Institute of Technology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Karlsruhe Institute of Technology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9399
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Karlsruhe Institute of Technology (KIT) is an educational service provider that offers research based scientific education. The institute offers research programs in the areas of biology, chemistry, and process engineering, mechanical and electrical engineering, physics and mathematics, natural and built environment, and informatics, economics, society, and others. It also offers innovation management, and protection of intellectual property rights through the technology marketing and project initiation, negotiation of license agreements, and initiation and support of IP-based spinoffs, start-ups and shareholdings. The institute offers research services such as advice for politicians, research funding, technology transfer and technical services. It operates institutes for applied business studies and management, applied materials, human and industrial engineering, vocational and general education, process engineering in life sciences, and telematics and transport studies, among others. KIT is headquartered in Karlsruhe, Germany.

Karlsruhe Institute of Technology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
amcure Raises USD6.4 Million in Series B Financing 10
Equity Offering 12
Lumobiotics Spin-Off from Karlsruhe Institute of Technology 12
amcure Spin-Off from from Karlsruhe Institute of Technology 13
Karlsruhe Institute of Technology – Key Competitors 14
Karlsruhe Institute of Technology – Key Employees 15
Karlsruhe Institute of Technology – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Sep 06, 2017: Bone Marrow Models to Study Blood and Musculoskeletal Disorders 17
Other Significant Developments 18
Sep 27, 2017: Merck Provides Update on EU’s Horizon 2020 Program to Improve Biopharmaceutical Downstream Processing 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Key Facts 2
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Karlsruhe Institute of Technology, Deals By Therapy Area, 2012 to YTD 2018 8
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
amcure Raises USD6.4 Million in Series B Financing 10
Lumobiotics Spin-Off from Karlsruhe Institute of Technology 12
amcure Spin-Off from from Karlsruhe Institute of Technology 13
Karlsruhe Institute of Technology, Key Competitors 14
Karlsruhe Institute of Technology, Key Employees 15
Karlsruhe Institute of Technology, Other Locations 16
Karlsruhe Institute of Technology, Subsidiaries 16

List of Figures
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Karlsruhe Institute of Technology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Karlsruhe Institute of Technology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • First Light Biosciences Inc:製品パイプライン分析
    Summary First Light Biosciences Inc (FLB) is a medical device company that develops and manufactures automated medical diagnostic products for detection of healthcare associated infections. The company’s product include multipath analyzer. Its multipath analyzer detects resistant and sensitive staph …
  • HCL Infosystems Limited:企業の戦略・SWOT・財務分析
    HCL Infosystems Limited - Strategy, SWOT and Corporate Finance Report Summary HCL Infosystems Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Falck Renewables S.p.A. (FKR):電力:M&Aディール及び事業提携情報
    Summary Falck Renewables S.p.A. (Falck Renewables), formerly Actelios S.p.A that develops, designs, constructs and manages energy production plants. It operates as a subsidiary of Falck S.p.A. The company produces clean energy from various renewable sources including wind energy, solar energy, bioma …
  • Vivimed Labs Ltd (VIVIMEDLAB):企業の財務・戦略的SWOT分析
    Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Korea East-West Power Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Korea East-West Power Co., Ltd. (EWP), subsidiary of Korea Electric Power Corporation, is a state-owned electric utility that generates and supplies electricity. It produces electricity from various sources including coal, oil, liquefied natural gas, mini hydro, and renewable sources such as …
  • ReShape Lifesciences Inc (RSLS)-医療機器分野:企業M&A・提携分析
    Summary ReShape Lifesciences Inc(ReShape Lifesciences) formerly known as EnteroMedics Inc, is a medical equipment provider that offers therapeutic and neuroregulator systems. The company designs and develops medical devices for the treatment of obesity and other disorders. It develops VBLOC therapy …
  • WH Group Limited (288):企業の財務・戦略的SWOT分析
    WH Group Limited (288) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Smartac Group China Holdings Ltd (395):企業の財務・戦略的SWOT分析
    Smartac Group China Holdings Ltd (395) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Xtant Medical Holdings Inc (XTNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Diamond Offshore Drilling, Inc.:企業の戦略・SWOT・財務情報
    Diamond Offshore Drilling, Inc. - Strategy, SWOT and Corporate Finance Report Summary Diamond Offshore Drilling, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Corporate Office Properties Trust:企業の戦略・SWOT・財務情報
    Corporate Office Properties Trust - Strategy, SWOT and Corporate Finance Report Summary Corporate Office Properties Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Companhia Energetica de Sao Paulo (CESP6):企業の財務・戦略的SWOT分析
    Companhia Energetica de Sao Paulo (CESP6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Theradex Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Theradex Systems Inc (Theradex) is a research organization that provides clinical trials monitoring services. The organization develops medical devices, pharmaceutical compounds and diagnostic tests in the areas of oncology and life-threatening diseases. It provides services such as clinical …
  • Nuclear Power Corporation of India Ltd:企業の戦略的SWOT分析
    Nuclear Power Corporation of India Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • QVC Inc:企業の戦略的SWOT分析
    QVC Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Medifocus Inc (MFS):製薬・医療:M&Aディール及び事業提携情報
    Summary Medifocus Inc (Medifocus) is a medical technology company. The company develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate. Its technology platforms includes endo-thermotherapy platform, a catheter-based …
  • Massachusetts Eye and Ear Infirmary-製薬・医療分野:企業M&A・提携分析
    Summary Massachusetts Eye and Ear Infirmary (MEE) is a healthcare service provider that offers primary, medical and surgical care services. The hospital offers services through departments such as ophthalmology, otolaryngology and patient care services. Its patient care services include patient educ …
  • AutoZone Inc (AZO):企業の財務・戦略的SWOT分析
    AutoZone Inc (AZO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Rexel S.A.:戦略・SWOT・企業財務分析
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Airservices Australia:企業の戦略的SWOT分析
    Airservices Australia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆